Amicus Therapeutics Inc (FOLD) support and resistance · rev $528.3M
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
This page maps Amicus Therapeutics Inc (FOLD) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
FOLD currently screens at market cap $1.80B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new FOLD 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the FOLD quote page for the session range and the stock page for the full model.
Not investment advice.